University of California, Irvine - UCI Medical Center
Orange, California, 92868, United States
Location contact
Frances Dang, MD
CONTACT
Frances Dang, MD
SUB_INVESTIGATOR
Jason Samarasena, MD, MBA
PRINCIPAL_INVESTIGATOR
NCT Number: NCT07178821
Peroral endoscopic myotomy (POEM) is an effective, minimally invasive treatment for achalasia, offering excellent rates of symptom relief. However, a significant drawback is the high incidence of gastroesophageal reflux disease (GERD) following the procedure. One proposed technical modification, the selective preservation of the sling fibers during gastric myotomy (SFP-POEM), may reduce this risk without compromising efficacy as compared to a conventional POEM procedure, which includes myotomy of the sling fibers. In this study, adults with achalasia will be randomly assigned to receive one of the two POEM technical approaches. Researchers will monitor whether preserving sling fibers reduces the rates of reflux esophagitis (classified as Los Angeles Grade B or higher) on follow-up endoscopy. Participants will be followed for up to 1 year after the procedure.
Trial opening soon.
Get Notified18 year and older
All sexes
Interventional
Not applicable
Orange, California, 92868, United States
Frances Dang, MD
CONTACT
Frances Dang, MD
SUB_INVESTIGATOR
Jason Samarasena, MD, MBA
PRINCIPAL_INVESTIGATOR
Achalasia is a rare esophageal motility disorder treated effectively with peroral endoscopic myotomy (POEM). However, post-procedure gastroesophageal reflux disease (GERD) is a common complication, reported in up to 65% of cases. One proposed technical modification - the selective preservation of gastric sling fibers - may help reduce reflux by maintaining part of the native anti-reflux mechanism.
This is a single-blinded, multicenter randomized controlled trial comparing sling fiber preservation (SFP) POEM versus conventional POEM in adult patients with achalasia. Patients are randomized 1:1 to either technique. The primary endpoint is the incidence of significant reflux esophagitis (LA esophagitis grade B or higher) at 3 months post-procedure endoscopy. Secondary outcomes include acid exposure time on pH impedence monitoring, symptomatic reflux (GerdQ), PPI usage, technical and clinical success, and adverse events. Follow-up continues for 12 months.
The study aims to determine whether the SFP-POEM technique reduces acid reflux without compromising treatment efficacy.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
(Participants must meet all of the following):
Exclusion criteria
(Participants will be excluded if any of the following apply):
Standard posterior POEM with full-thickness myotomy, including both circular and gastric sling muscle fibers.
Posterior POEM with selective preservation of gastric sling fibers by limiting myotomy to the right of the second penetrating vessel.
Other names: SFP-POEM
Time frame: 3 months post-procedure
Reflux esophagitis will be assessed by upper endoscopy (EGD) at 3 months post-POEM. Grading will be based on the Los Angeles (LA) Classification. Significant reflux is defined as LA Grade B or higher.
Time frame: 3 months post-procedure
Esophageal acid exposure will be measured by 24-hour Bravo pH monitoring performed off PPIs for at least 2 weeks. Reflux severity is quantified using acid exposure time (%) and the DeMeester composite score. The DeMeester score has no fixed maximum; higher values indicate greater esophageal acid exposure. Pathologic reflux is defined as acid exposure time >6% and/or a DeMeester score >14.72.
Time frame: 3, 6, 12 months post-procedure
Symptom-based GERD assessment will be measured using the Gastroesophageal Reflux Disease Questionnaire (GerdQ), which ranges from 0 to 18. Higher scores indicate more frequent or severe reflux symptoms, while lower scores indicate fewer or no symptoms. A score >7 is considered clinically significant.
Time frame: 3, 6, 12 months post-procedure
Assessment of ongoing PPI therapy and symptom-guided discontinuation based on reflux control.
Time frame: 3, 6 and 12 months post-procedure
Symptom improvement will be measured using the Eckardt Symptom Score, which ranges from 0 to 12. Higher scores indicate more severe symptoms (dysphagia, chest pain, regurgitation, and weight loss), while lower scores indicate symptom improvement. A score ≤ 3 is considered a successful clinical outcome.
Time frame: During procedure
Technical success defined as completion of full-length myotomy as planned.
Time frame: Within 1 month post-procedure
Monitoring of intra- and post-procedural complications, including bleeding, perforation, capno-peritoneum, leak, infection, and other unexpected events.
Contact information is provided by the study sponsor or research team.
Frances Dang, MD, MSc
CONTACT
Jason Samarasena, MD
CONTACT
University of California, Irvine
Other
Sling-Fiber Preservation POEM vs. Conventional POEM for Reducing Post-POEM GERD: A Randomized Control Trial
Acronym: SFP-POEM
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07334639
Achalasia, Esophageal, Body Weight
Jerusalem, Israel
View Trial DetailsNCT07287787
Achalasia, Esophageal, Deglutition Disorders
View Trial DetailsNCT07458555
Achalasia, Esophageal, Deglutition Disorders
Dallas, Texas, United States
View Trial DetailsNCT07181070
Achalasia, Achalasia, Esophageal
Naples, Italy
View Trial Details